SCHEMBL7915359

SCHEMBL7915359

CSC(=O)OCN(CCCC[C@H](N)C(=O)O)C(C)=NO

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 9/20 0.41
NOS1 P29475 7/20 0.41
NOS3 P29474 6/20 0.41
CYP2C19 P33261 3/20 0.41
THPO P40225 1/20 0.41
CYP1A2 P05177 2/20 0.40
TSHR P16473 2/20 0.40
CYP3A4 P08684 1/20 0.40
BLM P54132 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
GSR P00390 1/20 0.36
GLA P06280 1/20 0.36
NFKB1 P19838 1/20 0.36
APEX1 P27695 1/20 0.36
DDAH1 O94760 1/20 0.35
ARG1 P05089 1/20 0.34
ARG2 P78540 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7915353 1.00 NOS2 (0.41) NOS2NOS1NOS3CYP2C19THPO
SCHEMBL7901856 0.88 NOS2 (0.42) NOS2NOS1NOS3CYP2C19CYP1A2
SCHEMBL7901861 0.88 NOS2 (0.42) NOS2NOS1NOS3CYP2C19CYP1A2
SCHEMBL7911437 0.86 NOS2 (0.40) NOS2NOS1NOS3CYP2C19CYP1A2
SCHEMBL7911433 0.86 NOS2 (0.40) NOS2NOS1NOS3CYP2C19CYP1A2
SCHEMBL7912058 0.84 NOS2 (0.39) NOS2NOS1NOS3CYP2C19CYP1A2
SCHEMBL7912070 0.84 NOS2 (0.39) NOS2NOS1NOS3CYP2C19CYP1A2
SCHEMBL7901710 0.80 SLC1A5 (0.41) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7901714 0.80 SLC1A5 (0.41) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL8821899 0.77 NOS2 (0.39) NOS2NOS1NOS3CYP2C19THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US claimed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP claimed
EP-0885188-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-12-23 EP claimed
WO-1997032844-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1997-09-12 WO claimed
EP-0885188-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-12-23 EP disclosed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO disclosed
WO-1997032844-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1997-09-12 WO disclosed